Getting your Trinity Audio player ready...
FRANKFURT, Oct 30 (Reuters) – Germany’s largest drugmaker
Bayer said it agreed with Schiff Nutrition
International to take over the U.S. vitamins and
nutritional supplements maker for $1.2 billion.
Bayer said on Tuesday it is offering $34 per share in cash.
Closing is subject to customary closing conditions and is
expected by year end 2012, it added.
Schiff posted sales of $259 million for its fiscal year
ended May 31, according to Bayer.
